End-of-day quote
Taipei Exchange
23:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
22.6
TWD
|
-2.80%
|
|
+11.60%
|
+66.79%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,309
|
1,528
|
1,490
|
2,071
|
1,438
|
1,898
|
Enterprise Value (EV)
1 |
1,430
|
1,768
|
1,880
|
1,722
|
2,837
|
2,654
|
P/E ratio
|
14.1
x
|
17.3
x
|
23.9
x
|
57.3
x
|
-27.4
x
|
136
x
|
Yield
|
12.4%
|
0.66%
|
0.67%
|
2.69%
|
-
|
-
|
Capitalization / Revenue
|
2.38
x
|
2.11
x
|
4.39
x
|
2.93
x
|
1.62
x
|
3.67
x
|
EV / Revenue
|
2.6
x
|
2.45
x
|
5.54
x
|
2.44
x
|
3.19
x
|
5.14
x
|
EV / EBITDA
|
-88.2
x
|
47.4
x
|
-151
x
|
630
x
|
-3,490
x
|
-51.1
x
|
EV / FCF
|
-3.07
x
|
-49.8
x
|
42.1
x
|
-4.53
x
|
-1.98
x
|
18.6
x
|
FCF Yield
|
-32.5%
|
-2.01%
|
2.37%
|
-22.1%
|
-50.6%
|
5.36%
|
Price to Book
|
1
x
|
1.2
x
|
1.07
x
|
1.16
x
|
0.97
x
|
1.22
x
|
Nbr of stocks (in thousands)
|
115,001
|
116,107
|
120,412
|
139,464
|
136,988
|
140,049
|
Reference price
2 |
11.38
|
13.16
|
12.37
|
14.85
|
10.50
|
13.55
|
Announcement Date
|
01/04/19
|
29/03/20
|
31/03/21
|
21/03/22
|
21/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
550.7
|
722.6
|
339.2
|
706.3
|
888.9
|
516.5
|
EBITDA
1 |
-16.22
|
37.29
|
-12.49
|
2.731
|
-0.813
|
-51.91
|
EBIT
1 |
-27.88
|
24.75
|
-24.34
|
-24.03
|
-41.77
|
-98.59
|
Operating Margin
|
-5.06%
|
3.42%
|
-7.18%
|
-3.4%
|
-4.7%
|
-19.09%
|
Earnings before Tax (EBT)
1 |
88.19
|
62.39
|
-11.18
|
163.2
|
-160.4
|
75.77
|
Net income
1 |
88.84
|
103.9
|
61.77
|
36.17
|
-52.81
|
19.89
|
Net margin
|
16.13%
|
14.38%
|
18.21%
|
5.12%
|
-5.94%
|
3.85%
|
EPS
2 |
0.8077
|
0.7619
|
0.5182
|
0.2594
|
-0.3836
|
0.0997
|
Free Cash Flow
1 |
-465.5
|
-35.5
|
44.61
|
-379.7
|
-1,436
|
142.4
|
FCF margin
|
-84.53%
|
-4.91%
|
13.15%
|
-53.76%
|
-161.54%
|
27.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
72.22%
|
-
|
-
|
715.98%
|
Dividend per Share
2 |
1.410
|
0.0864
|
0.0835
|
0.4000
|
-
|
-
|
Announcement Date
|
01/04/19
|
29/03/20
|
31/03/21
|
21/03/22
|
21/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
121
|
240
|
390
|
-
|
1,399
|
757
|
Net Cash position
1 |
-
|
-
|
-
|
350
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-7.473
x
|
6.427
x
|
-31.21
x
|
-
|
-1,721
x
|
-14.58
x
|
Free Cash Flow
1 |
-465
|
-35.5
|
44.6
|
-380
|
-1,436
|
142
|
ROE (net income / shareholders' equity)
|
6.71%
|
3.65%
|
-0.41%
|
6.06%
|
-4.36%
|
1.99%
|
ROA (Net income/ Total Assets)
|
-1.01%
|
0.8%
|
-0.76%
|
-0.41%
|
-0.47%
|
-1%
|
Assets
1 |
-8,777
|
13,003
|
-8,084
|
-8,791
|
11,331
|
-1,984
|
Book Value Per Share
2 |
11.40
|
11.00
|
11.50
|
12.80
|
10.80
|
11.10
|
Cash Flow per Share
2 |
2.820
|
2.060
|
1.370
|
3.560
|
3.250
|
2.480
|
Capex
1 |
26.3
|
4.83
|
0.91
|
8.41
|
121
|
39.4
|
Capex / Sales
|
4.78%
|
0.67%
|
0.27%
|
1.19%
|
13.56%
|
7.64%
|
Announcement Date
|
01/04/19
|
29/03/20
|
31/03/21
|
21/03/22
|
21/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +66.79% | 102M | | +2.56% | 101B | | -1.20% | 65.99B | | +47.62% | 41.98B | | +15.99% | 38.65B | | +4.25% | 32.16B | | +8.78% | 19.21B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|